Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation

Leuk Lymphoma. 2020 Dec;61(12):3024-3026. doi: 10.1080/10428194.2020.1791855. Epub 2020 Jul 11.

Affiliations

¹ Department of Pharmacy, NewYork-Presbyterian/Weill Cornell Medical Center.
² Division of Hematology and Oncology, Department of Medicine, NewYork-Presbyterian, Weill Cornell Medical Center.
³ Division of Infectious Diseases, Department of Medicine, NewYork-Presbyterian, Weill Cornell Medical Center.

PMID: 32654572
DOI: 10.1080/10428194.2020.1791855

No abstract available

Publication types

Letter

MeSH terms

Alemtuzumab / adverse effects
Cytomegalovirus Infections*
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Transplantation Conditioning / adverse effects
Whole-Body Irradiation

Substances

Alemtuzumab